Amgen Taiwan’s General Manager Daniel Villegas began his career in the fast-moving consumer goods space before transitioning into biopharmaceuticals. His professional journey has spanned four continents and covered various therapeutic areas, from rare diseases to immunology. A California native, Villegas earned his BA from San Diego State University and MBA from Michigan State University. In…
Despite being held virtually this year due to COVID-19 restrictions, BIO Asia-Taiwan 2021 gave attendees the chance to enjoy a broad range of presentations, panel discussions, and business networking opportunities from the comfort of their homes. For the first time in its history, BIO Asia-Taiwan went completely online this year. The event, which took place…
A weekly snapshot of Taiwan business news stories brought to you by CommonWealth and AmCham Taiwan’s TOPICS Third UK-Taiwan Energy Dialogue Held Virtually in July Taiwan’s Bureau of Energy and the British Office Taipei held the Third Taiwan-Britain Energy Dialogue on July 6, during which the two sides signed a memorandum of understanding to cooperate…
In an industry as dynamic and competitive as healthcare, standing out requires outstanding ingenuity, while still maintaining a dedication to patient wellbeing and care. For California-headquartered biopharmaceutical company Amgen, which last year celebrated 40 years of providing innovative and life-changing treatments to patients, being a leader is baked into its DNA. Over that period, 70%…
Combining on-site and online participants, exhibitors, and speakers, BIO Asia-Taiwan 2020 introduced hundreds of new biotech and biomedical developments, including many related to COVID-19. In a visual demonstration of how well Taiwan has controlled COVID-19, the island hosted Asia’s first major industry gathering since the onset of the pandemic, a biotech conference and exhibition appropriately…
Taiwan is making great strides in developing its biotech sector, but reaching the NT$ trillion mark in annual production value by 2025 won’t be easy. When the Biotech Innovation Organization (BIO), the world’s leading industry association for biotechnology, chose to hold its annual regional conference this summer in Taipei, it was a big boost for…
Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub – Is Taiwan Ready for the Top Spot?” That provocative topic was the theme of a half-day conference – held April 25 at the Chang Yung-Fa Foundation’s International Convention Center – that featured a number of prominent expert speakers and panelists from both Taiwan and internationally. The…
Hon Hai Ends 2016 on High Hon Hai Precision Industry Co. (also known as Foxconn) reported its full-year results on April 1, disclosing that the world’s largest contract manufacture of electronics saw record high earnings in 2016 of NT$148.66 billion (US$4.9 billion), up 1.22% from last year. Mirroring Taiwan’s overall exports, Hon Hai had been…
This is Part 1 of the cover story on Pharmaceuticals: Links to Part 2, Part 3 Several Taiwan biopharma companies have developed promising new drugs, and the new government taking office this month is expected to place even more emphasis on this sector. For the industry to become a major driver of economic growth, however, Taiwan…
The gene-editing technology with the unlikely name offers great potential for genetic engineering. While not yet a household word, CRISPR, the new gene-editing technology, has taken the science of genetic engineering by storm. More precise than competing technologies while involving a fraction of the time and effort, CRISPR is already having a strong impact…
